Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Pinto (Porto, Portugal), P. Mota (Porto, Portugal), N. Melo (Porto, Portugal), A. Morais (Porto, Portugal), H. Novais E Bastos (Porto, Portugal). Familial Pulmonary Fibrosis: experience from a tertiary hospital. 2370

Member's Comments

No comment yet.

Related content which might interest you: Cardiac sarcoidosis: a tertiary centre experience Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype Year: 2018 Primary Pulmonary Amyloidosis - The experience at a tertiary hospital on the Gold Coast, Australia Source: International Congress 2018 – CC6 Interstitial lung diseases Year: 2018 Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis? Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020 Pulmonary aspergillous; clinical features and outcomes in a tertiary care hospital Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Diffuse pulmonary ossification in Idiopathic Pulmonary Fibrosis: Forli 10-year experience Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017 Clinical experience with nintedanib for IPF in 3 UK tertiary referral centres Source: International Congress 2016 – IPF treatment II Year: 2016 Pulmonary embolism in children in a tertiary hospital in Bogota Colombia Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015 Non-Cystic Fibrosis Bronchiectasis in children: a single center experience. Source: International Congress 2019 – A mixture of rare lung diseases Year: 2019 Clinical findings at initial presentation of IPF patients at a university hospital referral center Source: International Congress 2014 – ILDs 5 Year: 2014 Idiopathic Pulmonary Fibrosis: mortality trends in Chile Source: International Congress 2019 – Interstitial lung disease registries Year: 2019 Types of interstitial lung diseases and comparison on survival of idiopathic and secondary types in a tertiary care setting of Sri Lanka Source: International Congress 2014 – ILDs 6 Year: 2014 Pulmonary nocardiosis in renal transplant patients in a tertiary care hospital in Pakistan Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections Year: 2020 Follow-up of Congenital Lung Malformations (CLM) in a Pediatric tertiary center Source: International Congress 2018 – Orphan diseases in children Year: 2018 Role of Biomarkers for Predicting suspecting Malignant Mesothelioma in patients with Pleural Effusion presenting to a tertiary care hospital Source: International Congress 2019 – Pleural disease: applying the evidence Year: 2019 Clinical characteristics of patients with Idiopathic pulmonary fibrosis in a tertiary care center of a developing country Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Idiopathic pulmonary fibrosis and systemic sclerosis-interstitial lung disease: features at admission to a tertiary pulmonology unit. Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Pulmonary Alveolar Microlithiasis: From Diagnosis to Transplant: An Indian Experience Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019 Cystic fibrosis centre care – paediatrics Source: School Course 2013 - Cystic Fibrosis Year: 2013